KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Intangibles (2020 - 2025)

Historic Intangibles for AbCellera Biologics (ABCL) over the last 6 years, with Q3 2025 value amounting to $39.3 million.

  • AbCellera Biologics' Intangibles fell 2521.25% to $39.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.3 million, marking a year-over-year decrease of 2521.25%. This contributed to the annual value of $42.1 million for FY2024, which is 6502.97% down from last year.
  • Latest data reveals that AbCellera Biologics reported Intangibles of $39.3 million as of Q3 2025, which was down 2521.25% from $40.3 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Intangibles ranged from a high of $163.0 million in Q3 2022 and a low of $39.3 million during Q3 2025
  • Over the past 5 years, AbCellera Biologics' median Intangibles value was $120.4 million (recorded in 2023), while the average stood at $110.1 million.
  • Per our database at Business Quant, AbCellera Biologics' Intangibles surged by 3679.69% in 2021 and then tumbled by 6530.79% in 2025.
  • Quarter analysis of 5 years shows AbCellera Biologics' Intangibles stood at $161.0 million in 2021, then fell by 18.31% to $131.5 million in 2022, then dropped by 8.42% to $120.4 million in 2023, then plummeted by 65.03% to $42.1 million in 2024, then dropped by 6.63% to $39.3 million in 2025.
  • Its last three reported values are $39.3 million in Q3 2025, $40.3 million for Q2 2025, and $41.2 million during Q1 2025.